The extent of agreement between frozen and paraffin block data from axillary samples in patients with early-stage breast cancer

被引:0
|
作者
Dagistanli, Sevinc [1 ]
Bulut, Nilufer [2 ,4 ]
Sonmez, Suleyman [3 ]
机构
[1] Kanuni Sultan Suleyman Res & Training Hosp, Dept Gen Surg, Istanbul, Turkey
[2] Basaksehir Cam & Sakura City Hosp, Dept Med Oncol, Istanbul, Turkey
[3] Kanuni Sultan Suleyman Res & Training Hosp, Dept Radiol, Istanbul, Turkey
[4] Basaksehir Cam & Sakura City Hosp, TR-34303 Istanbul, Turkey
关键词
Breast cancer axillary dissection; Frozen; Sentinel lymph node; SENTINEL LYMPH-NODE; SECTION; BIOPSY;
D O I
10.1016/j.anndiagpath.2022.152097
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Patients with early-stage breast cancer currently undergo sentinel lymph node dissection to evaluate the axillary region. Frozen tissue blocks are evaluated intra operatively and paraffin-embedded samples are studied postoperatively. We explored whether sentinel lymph node dissection adequately reflected axillary involvement (as revealed by the paraffin blocks) in patients with early-stage breast cancer; we sought to avoid axillary dissection.Methods: The agreement/non-agreement rates between the results of axillary ultrasonography and biopsy, sentinel lymph node and axillary dissections, and frozen and paraffin block results, were retrospectively analyzed for 200 patients with early-stage breast cancer. The positive predictive values and accuracies were recorded in those who were positive on both ultrasonography and biopsy. The negative predictive values were calculated for doubly negative cases. Results: The frozen and paraffin block results disagreed in 19 (9.5 %) cases and agreed in 181 (90.5 %). The frozen block and dissection results differed in five of 38 patients who underwent axillary dissection (AD) (one patient did not undergo AD); the results were in agreement in 32. Of the 19 block-disagreement cases, 16 were in the non-neoadjuvant chemotherapy (NAC) group and three in the NAC treatment group. Clinically, the negative predictive values of the frozen and paraffin block data were 80 % in patients lacking axillary involvement.Conclusion: Paraffin block evaluations only (thus, without frozen block examinations) of early-stage breast cancer lymph nodes seem to be sufficient to guide treatment. Also, a thorough clinical examination (with ultrasonog-raphy and axillary biopsy) reduces the dissection rate and the associated functional impairments.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection
    Kim, Ga Ram
    Choi, Ji Soo
    Han, Boo-Kyung
    Lee, Jeong Eon
    Nam, Seok Jin
    Ko, Eun Young
    Ko, Eun Sook
    Lee, Se Kyung
    RADIOLOGY, 2018, 288 (01) : 55 - 63
  • [42] Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast Cancer
    Parikh, R. R.
    Khan, A. J.
    Goyal, S.
    Ahlawat, S.
    Moran, M. S.
    Haffty, B. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S228 - S229
  • [43] The relationship between treatment intensity and characteristics of patients with early-stage breast cancer.
    Franks, Jeffrey
    Caston, Nicole
    Williams, Courtney
    Azuero, Andres
    Aswani, Monica S.
    Gidwani, Risha
    Rocque, Gabrielle Betty
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [44] Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
    Beaver, Julia A.
    Jelovac, Danijela
    Balukrishna, Sasidharan
    Cochran, Rory L.
    Croessmann, Sarah
    Zabransky, Daniel J.
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cidado, Justin
    Blair, Brian G.
    Chu, David
    Burns, Timothy
    Higgins, Michaela J.
    Stearns, Vered
    Jacobs, Lisa
    Habibi, Mehran
    Lange, Julie
    Hurley, Paula J.
    Lauring, Josh
    VanDenBerg, Dustin A.
    Kessler, Jill
    Jeter, Stacie
    Samuels, Michael L.
    Maar, Dianna
    Cope, Leslie
    Cimino-Mathews, Ashley
    Argani, Pedram
    Wolff, Antonio C.
    Park, Ben Ho
    CLINICAL CANCER RESEARCH, 2014, 20 (10) : 2643 - 2650
  • [45] Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
    Smerage, J. B.
    Breast Diseases, 2015, 26 (01): : 35 - 36
  • [46] The declining use of axillary dissection in patients with early stage breast cancer
    Xianglin Du
    Jean L. Freeman
    James S. Goodwin
    Breast Cancer Research and Treatment, 1999, 53 : 137 - 144
  • [47] The declining use of axillary dissection in patients with early stage breast cancer
    Du, XL
    Freeman, JL
    Goodwin, JS
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 53 (02) : 137 - 144
  • [48] Special Considerations in Patients with Early-Stage Breast Cancer and Survivors
    Partin, Jessica F.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2022, 49 (01) : 195 - 208
  • [49] Best Use of Neratinib in Patients With Early-Stage Breast Cancer
    O'Shaughnessy, Joyce A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 11 - 16
  • [50] Managing early-stage breast cancer in your older patients
    Witherby, Sabrina M.
    Muss, Hyman B.
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1003 - 1012